Lower CSF MHPG predicts short-term risk for suicide attempt

International Journal of Neuropsychopharmacology

Volumn 12, Issue 10, 2009, Pages 1327-1335

  Galfalvy, Hanga ^a   Currier, Dianne ^a   Oquendo, Maria A ^a   Sullivan, Gregory ^a   Huang, Yung Yu ^a   John Mann, J ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

CSF MHPG; depression; mediation model; smoking; suicide attempt

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; NORADRENALIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MULTIVARIATE ANALYSIS; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; SELF CONCEPT; SMOKING; STATISTICAL SIGNIFICANCE; SUICIDE ATTEMPT; SURVIVAL; CEREBROSPINAL FLUID; COHORT ANALYSIS; COMPARATIVE STUDY; MIDDLE AGED; PREDICTION AND FORECASTING; PSYCHOLOGICAL ASPECT; RISK FACTOR; TIME;

ADULT; BIOLOGICAL MARKERS; BIPOLAR DISORDER; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SUICIDE, ATTEMPTED; TIME FACTORS;

EID: 77954055416     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145709990228     Document Type: Article

References (41)

1. Agren H, Niklasson F (1986). Suicidal potential in depression: focus on CSF monoamine and purine metabolites. Psychopharmacology Bulletin 22, 656-660. (Pubitemid 17183361)
2. Alloy LB, Abramson LY, Whitehouse WG, Hogan ME, et al. (1999). Depressogenic cognitive styles : predictive validity, information processing and personality characteristics, and developmental origins. Behavior Research and Therapy 37, 503-531. (Pubitemid 29225205)
3. Anderson SM (1990). The inevitability of future suffering: The role of depressive predictive certainty in depression. Social Cognition 8, 203-228.
4. Arango V, Ernsberger P, Marzuk PM, Chen JS, et al. (1990). Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Archives of General Psychiatry 47, 1038-1047. (Pubitemid 20377514)
5. Arango V, Ernsberger P, Sved AF, Mann JJ (1993). Quantitative autoradiography of a1- and a2-adrenergic receptors in the cerebral cortex of controls and suicide victims. Brain Research 630, 271-282.
6. Arango V, Underwood MD, Mann JJ (1996). Fewer pigmented locus coeruleus neurons in suicide victims : preliminary results. Biological Psychiatry 39, 112-120. (Pubitemid 26045298)
7. Baron RM, Kenny DA (1986). The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology 51, 1173-1182.
8. Biegon A, Israeli M (1988). Regionally selective increases in b-adrenergic receptor density in the brains of suicide victims. Brain Research 442, 199-203. (Pubitemid 18065760)
9. Conner KR (2004). A call for research on planned vs. unplanned suicidal behavior. Suicide and Life-Threatening Behavior 34, 89-98. (Pubitemid 38702987)
10. Cooper SJ, Kelly CB, King DJ (1992). 5-Hydroxyindoleacetic acid in cerebrospinal fluid and prediction of suicidal behaviour in schizophrenia. Lancet 340, 940-941.
11. Dumais A, Lesage AD, Lalovic A, Seguin M, et al. (2005). Is violent method of suicide a behavioral marker of lifetime aggression? American Journal of Psychiatry 162, 1375-1378. (Pubitemid 40905591)
12. Engstrom G, Alling C, Blennow K, Regnell G, Traskman-Bendz L (1999). Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls. European Neuropsychopharmacology 9, 399-405. (Pubitemid 29415719)
13. First MB, Spitzer RL, Gibbon M, Williams JBW (2002). Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). Biometrics Research, New York State Psychiatric Institute, New York.
14. First MB, Spitzer RL, Gibbon M, Williams JMG, Benjamin L (1996). Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II) (Version 2.0). Biometrics Research Department, New York State Psychiatric Institute, New York.
15. Harmer CJ, Shelley NC, Cowen PJ, Goodwin GM (2004). Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. American Journal of Psychiatry 161, 1256-1263. (Pubitemid 38859176)
16. Kessler RC, Borges G, Sampson N, Miller M, Nock MK (2008). The association between smoking and subsequent suicide-related outcomes in the National Comorbidity Survey panel sample. Molecular Psychiatry. Published online : 22 July 2008. doi :10.1038/mp.2008.78.
17. Klimek V, Zhu MY, Dilley G, Konick L, et al. (2001). Effects of long-term cigarette smoking on the human locus coeruleus. Archives of General Psychiatry 58, 821-827. (Pubitemid 32979299)
18. Leon AC, Friedman RA, Sweeney JA, Brown RP, Mann JJ (1990). Statistical issues in the identification of risk factors for suicidal behavior: the application of survival analysis. Psychiatry Research 31, 99-108. (Pubitemid 20049548)
19. Lester D (1995). The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals : a meta-analysis. Pharmacopsychiatry 28, 45-50.
20. Mann JJ, Malone KM, Sweeney JA, Brown RP, et al. (1996). Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients. Neuropsychopharmacology 15, 576-586. (Pubitemid 26400762)
21. Mann JJ, Stanley M, McBride PA, McEwen BS (1986). Increased serotonin2 and b-adrenergic receptor binding in the frontal cortices of suicide victims. Archives of General Psychiatry 43, 954-959. (Pubitemid 17168415)
22. Mann JJ, Waternaux C, Haas GL, Malone KM (1999). Toward a clinical model of suicidal behavior in psychiatric patients. American Journal of Psychiatry 156, 181-189. (Pubitemid 29077107)
23. Nordstro¨ P, Samuelsson M, A°sberg M, Tra¨kman-Bendz L, et al. (1994). CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide and Life-Threatening Behavior 24, 1-9. (Pubitemid 24116677)
24. Oquendo MA, Galfalvy H, Russo S, Ellis SP, et al. (2004). Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. American Journal of Psychiatry 161, 1433-1441. (Pubitemid 38989097)
25. Oquendo MA, Halberstam B, Mann JJ (2003). Risk factors for suicidal behavior: the utility and limitations of research instruments. In : First MB (Ed.), Standardized Evaluation in Clinical Practice (pp. 103-130). Washington, DC: American Psychiatric Publishing Inc.
26. Ordway GA, Klimek V (2001). Noradrenergic pathology in psychiatric disorders : postmortem studies. CNS Spectrums 6, 697-703. (Pubitemid 34546967)
27. Ordway GA, Smith KS, Haycock JW (1994a). Elevated tyrosine hydroxylase in the locus coeruleus of suicide victims. Journal of Neurochemistry 62, 680-685. (Pubitemid 24041338)
28. Ordway GA, Widdowson PS, Smith KS, Halaris A (1994b). Agonist binding to a2-adrenoceptors is elevated in the locus coeruleus from victims of suicide. Journal of Neurochemistry 63, 617-624.
29. Pandey GN, Dwivedi Y (2007). Noradrenergic function in suicide. Archives of Suicide Research 11, 235-246.
30. Placidi GP, Oquendo MA, Malone KM, Huang YY, et al. (2001). Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels. Biological Psychiatry 50, 783-791. (Pubitemid 33086766)
31. Roy A, Ninan PT, Mazonson A, Pickar D, et al. (1985). CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide. Psychological Medicine 15, 335-340. (Pubitemid 15117707)
32. Ruhe HG, Mason NS, Schene AH (2007). Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Molecular Psychiatry 12, 331-359. (Pubitemid 46496835)
33. Sher L, Carballo JJ, Grunebaum MF, Burke AK, et al. (2006). A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder. Bipolar Disorders 8, 543-550. (Pubitemid 44567136)
34. Sher L, Oquendo MA, Grunebaum MF, Burke AK, et al. (2007). CSF monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol dependence. European Neuropsychopharmacology 17, 12-15. (Pubitemid 44751407)
35. Shrout PE, Bolger N (2002). Mediation in experimental and nonexperimental studies : new procedures and recommendations. Psychological Methods 7, 422-445.
36. Sunnqvist C, Westrin A, Traskman-Bendz L (2008). Suicide attempters: biological stress markers and adverse life events. European Archives of Psychiatry & Clinical Neuroscience 258, 456-462.
37. Tra¨kman L, A°sberg M, Bertilsson L, Sjo?trand L (1981). Monoamine metabolites in CSF and suicidal behavior. Archives of General Psychiatry 38, 631-636. (Pubitemid 11064819)
38. Traskman-Bendz L, Alling C, Oreland L, Regnell G, et al. (1992). Prediction of suicidal behavior from biologic tests. Journal of Clinical Psychopharmacology 12, 21S-26S.
39. Virkkunen M, De Jong J, Bartko J, Linnoila M (1989). Psychobiological concomitants of history of suicide attempts among violent offenders and impulsive fire setters. Archives of General Psychiatry 46, 604-606. (Pubitemid 19180338)
40. Volavka J, Bilder R, Nolan K (2004). Catecholamines and aggression: the role of COMT and MAO Polymorphisms. Annals of the New York Academy of Sciences 1036, 393-398. (Pubitemid 40576108)
41. Wichman AL, Reich DA, Weary G (2006). Perceived likelihood as a measure of optimism and pessimism: support for the Future Events Scale. Psychological Assessment 18, 215-219. (Pubitemid 44106663)